Sign in Subscribe
Theft

Stolen Novo Nordisk Medicines Pose Severe Security and Public Health Concerns

Strategic Insights

— 2 min read

Reports of a serious breach in the cold chain of several consignments of Novo Nordisk's injectable medicines, including Wegovy (semaglutide), an anti-obesity drug, from the company's Bhiwandi hub have raised alarm bells among healthcare experts. The stolen stock, which included rDNA-based insulin products and Wegovy pens, was meant for multiple cities including Nagpur, Raipur, Cuttack, and Kolkata. If taken without prescription and medical supervision, Wegovy can trigger severe side effects such as nausea, vomiting, stomach paralysis, gallstones, thyroid complications, and in rare cases, blindness. The Central Drugs Standard Control Organization (CDSCO) and the Drug Controller General of India (DCGI) have issued a nationwide alert, advising doctors, healthcare professionals, patients, and consumers to remain vigilant and to dispense or purchase these medicines only from authorized sources with valid invoices.

Key Takeaways:

  • Multiple consignments of Novo Nordisk's injectable medicines, including Wegovy (semaglutide), were stolen in transit from the company's Bhiwandi hub in a serious security and public health concern.
  • The stolen medicines, which included rDNA-based insulin products and Wegovy pens, were bound for multiple cities, including Nagpur, Raipur, Cuttack, and Kolkata.
  • If taken without prescription and medical supervision, Wegovy can trigger severe side effects such as nausea, vomiting, stomach paralysis, gallstones, thyroid complications, and in rare cases, blindness.
  • The Central Drugs Standard Control Organization (CDSCO) and the Drug Controller General of India (DCGI) have issued a nationwide alert, advising doctors, healthcare professionals, patients, and consumers to remain vigilant and to dispense or purchase these medicines only from authorized sources with valid invoices.
  • Doctors, with expertise in bariatric surgery, have warned about the dangers of unsupervised use of Wegovy, emphasizing the need for a strictly monitored dose-escalation regimen.
  • The CDSCO has instructed all state and UT drug controllers, along with its zonal and sub-zonal offices, to keep strict surveillance on the movement of these products and take action under the Drugs & Cosmetics Act, 1940.

Statistics:

  • The stolen consignments of Novo Nordisk's injectable medicines include 0.25 mg, 0.5 mg, and 1 mg doses of Wegovy injections, as well as insulin degludec and insulin aspart.
  • The cold chain breach may render the medicines unsafe for patient use, compromising their potency and increasing the risk of severe side effects.
  • The nationwide alert issued by the CDSCO and DCGI is a critical measure to prevent the misuse of Wegovy and other injectable medicines.

Sources:

  • "Stolen consignments of Novo Nordisk's injectable medicines pose serious security and public health concerns" by Indian National Press (Bombay) Pvt. Ltd., distributed by Contify.com
  • "CDSCO issues nationwide alert on stolen consignments of Novo Nordisk's injectable medicines" by Indian National Press (Bombay) Pvt. Ltd., distributed by Contify.com
  • "Expert warns of severe side effects of unsupervised use of Wegovy" by Dr. Shashank Shah, Bariatric Surgeon and Obesity Specialist at Hinduja Hospital, Khar West, and Lilavati Hospital.

Read more